ISSN: 1755-5310 (Electronic)1755-5302 (Print)

Interventional Cardiology

Placenta, Blood Pressure, Anti-Inflammatory, Uterine, Cervix, Cytokine Output, Aplacental Illness, Pregnancy

The effects of placental ischemia on blood pressure and many facets seen in preeclampsia can be attenuated by inhibiting T cells either by blocking antigen presenting cells that interact with T cells or by deficiencies of T cells overall. Importantly, these data suggest the potential use for preeclampsia of anti-inflammatory drugs that target T-cell suppression. Such findings demonstrate the significance of targeting the repression of CD4 + T cells as an avenue for lowering blood pressure, cytokine output, anti-angiogenic factors, autoantibodies and uterine artery resistive index to enhance symptoms of late preeclampsia in women with PE. The aplacental illness is any placental disease, disorder, or pathology. The ischemic placental disease ends up becoming under-perfused when the placenta is attached to the uterine wall, causing uteroplacental ischemia. Placental disorders are known as pregnancy, accreta placenta, increta placenta or percreta placenta. Placental conditions are typically identified during the trimester by ultrasound (about 18 to 20 weeks into a pregnancy). Pregnancy happens as part or more of the cervix is covered by placenta. Furthermore, Scholarly Review is a quarterly review of a textbook linked to a teaching tutorial.

High Impact List of Articles

Relevant Topics in Clinical